PolyPid Ltd.
NASDAQ:PYPDBiotechnology
+$0.39 today
- Market cap
- $133.25M
- Beta
- 1.43
- P/E (TTM)
- -2.7
- EPS (TTM)
- -$1.53
Volume 0.30M
Average 0.09M
PYPD Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
PolyPid Ltd.NASDAQ: PYPD
Other Non-Cash Items · Q4 FY2025 · quarter ended Dec 2025
Other non-cash items of $8.47M in Q4 FY2025
Q4 FY2025 other non-cash items was $8.47M. Trailing-twelve-month other non-cash items was $34.17M. Over 3 fiscal years it compounded at +95.2% a year.
Context
- Other non-cash items increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other non-cash items holds near $8.47M or moves back toward the trailing-twelve-month quarterly average of $8.54M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 34.17M USD
- Year-over-year change
- +870.4%
- 4-year CAGR
- +63.8%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 34.17M | +870.4% |
| FY2024 | 2024-12-31 | 3.52M | -28.4% |
| FY2023 | 2023-12-31 | 4.92M | +7.0% |
| FY2022 | 2022-12-31 | 4.6M | -3.2% |
| FY2021 | 2021-12-31 | 4.75M | — |
Other Non-Cash Items vs competitors
How PYPD compares with its peers on the latest reported figures
- PYPD's LTM Dec 2025 other non-cash items of $34.17M is the 2nd largest of the 7 companies compared; the peer median is $91.64K.
- Over three fiscal years its annual growth of +95.2% compares with a peer median of +299.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $20.21B | +1471660.5% | +482.8% | — | |
| LTM Dec 2025 | $34.17M | — | +95.2% | — | |
| LTM Dec 2025 | $27.2M | +141.4% | — | 102.4% | |
| LTM Mar 2026 | $11.33M | +573.0% | +115.7% | — | |
| LTM Jun 2026 | $1.23M | — | — | 3.5% | |
| LTM Mar 2026 | $148K | -96.6% | — | — | |
| LTM Mar 2026 | $35.29K | -98.1% | — | — | |
| Peer median (excluding PYPD) | $91.64K | +141.4% | +299.3% | 53.0% | |
Competitors are the stored peer set for PYPD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (42.6M) | (39.56M) | (23.87M) | (29.02M) | (34.17M) |
| Depreciation & Amortization | 1.12M | 1.72M | 1.82M | 1.62M | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 4.35M | (1.08M) | (110K) | 1.92M | 0 |
| Accounts Receivables | 123K | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 2.22M | (3.1M) | (369K) | 1.64M | 0 |
| Other Working Capital | 2M | 2.02M | 259K | 279K | 0 |
| Other Non-Cash Items | 4.75M | 4.6M | 4.92M | 3.52M | 34.17M |
| Operating Cash Flow | (32.39M) | (34.32M) | (17.24M) | (21.96M) | 0 |
| Capital Expenditures | (2.99M) | (1.77M) | (196K) | (76K) | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (18.6M) | (21.35M) | 0 |
| Sales of Investments | 39.89M | 18.34M | 22.6M | 21.1M | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 36.9M | 16.58M | 3.8M | (330K) | 0 |
| Debt Repayment | 0 | 11.31M | (2.62M) | (3.32M) | 0 |
| Common Stock Issued | 1.03M | 5.12M | 12.72M | 35.86M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | (125K) | (125K) | 0 |
| Financing Cash Flow | 1.03M | 16.43M | 9.98M | 32.42M | 0 |
| Effect of Forex Changes | (41K) | 161K | 2K | 77K | (9.21M) |
| Net Change in Cash | 5.51M | (1.15M) | (3.45M) | 10.2M | (9.21M) |
| Free Cash Flow | (35.38M) | (36.08M) | (17.43M) | (22.04M) | 0 |
PolyPid Ltd.
NASDAQ:PYPD
Intrinsic Alpha fair value
Locked
Current Price
$6.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.